Skip to content
AnalystLens
Back to MRNABalance Sheet

Moderna, Inc. Accumulated OCI 2017-2026 | MRNA

Annual FY2017–FY2025 · quarterly through Q1 FY2026

Latest annual · FY2025

$45.0M

+550.0%YoY vs FY2024Source: 10-KFY2025

From −$1.2M in FY2017 to $45.0M in FY2025.

By quarter▲▼ vs a year before
Fiscal yearQ1Q2Q3Q4
FY26$25M+150.0%Not reportedNot reportedNot reported
FY25$10M+109.9%$23M+132.4%$27M+145.5%$45M+550.0%
FY24−$101M+62.2%−$71M+73.0%$11M+105.2%−$10M+91.9%
FY23−$267M−45.1%−$263M−9.6%−$211M+39.9%−$123M+66.8%
FY22−$184M−18500.0%−$240M−1600.0%−$351M−1232.3%−$370M−1441.7%

Shaded by size: darkest is the largest quarter shown; ringed is the latest reported; a dash marks a quarter with no separate figure. Each quarter sits by its period-end date.

Key Statistics

Trend DirectionGrowing
CAGR

+71.9%

FY2020
$3.0M
FY2025
$45.0M

5 years selected · on the chart

Accumulated OCI History

Year-over-year comparison from 10-K annual reports

  1. $45.0M
YoY changeLargest recent move−1441.7%in FY22Latest +550.0%

4 older moves run past ±150% (largest −1441.7%); point at, tap or drag across the bars to read one.

Accumulated OCI, period by period

PeriodValueChangeSource
FY2025$45.0M+550.0%10-K
FY2024−$10.0M+91.9%10-K
FY2023−$123.0M+66.8%10-K
FY2022−$370.0M−1441.7%10-K
FY2021−$24.0M−900.0%10-K
FY2020$3.0M+66.3%10-K
FY2019$1.8M+236.7%10-K
FY2018−$1.3M−14.1%10-K
FY2017−$1.2M—10-K

What is accumulated oci?

Accumulated other comprehensive income (OCI) includes unrealized gains and losses from foreign currency translation, available-for-sale securities, and pension adjustments.

What is Moderna, Inc.'s current accumulated oci?

Moderna, Inc. (MRNA) annual accumulated oci for 2025 was $45.0M, a 550.00% increase from 2024. Moderna, Inc. accumulated oci for the quarter ending March 31, 2026 was $25.0M.

What was Moderna, Inc.'s accumulated oci in 2024?

Moderna, Inc. annual accumulated oci for 2024 was $-10.0M, a 91.87% increase from 2023.

What was Moderna, Inc.'s accumulated oci in 2023?

Moderna, Inc. annual accumulated oci for 2023 was $-123.0M, a 66.76% increase from 2022.

What is Moderna, Inc.'s 5-year accumulated oci CAGR?

Moderna, Inc. accumulated oci grew at a compound annual growth rate (CAGR) of 71.88% from FY2020 to FY2025, going from $3.0M to $45.0M over 5 years.

Company
Moderna, Inc.
Ticker
MRNA
Sector
Healthcare
Industry
Biological Products, (No Diagnostic Substances)